The National Cancer Institute's Role in Advancing Health-Care Delivery Research.


Journal

Journal of the National Cancer Institute
ISSN: 1460-2105
Titre abrégé: J Natl Cancer Inst
Pays: United States
ID NLM: 7503089

Informations de publication

Date de publication:
11 01 2022
Historique:
received: 16 03 2021
revised: 26 04 2021
accepted: 13 05 2021
pubmed: 17 5 2021
medline: 25 2 2022
entrez: 16 5 2021
Statut: ppublish

Résumé

Improvements in cancer care delivery have the potential to reduce morbidity and mortality from cancer, however, challenges to delivery of recommended care limit progress. These challenges include growing demands for care, increasing treatment complexity, inadequate care coordination, dramatic increases in costs, persistent disparities in care, and insufficient use of evidence-based guidelines. Recognizing the important role of research in understanding and addressing these challenges, the National Cancer Institute created the Healthcare Delivery Research Program (HDRP) in 2015 as a catalyst for expanding work in this area. Health-care delivery research is a multidisciplinary effort which recognizes that care delivery occurs in a multilevel system encompassing individuals, health-care systems, and communities. HDRP staff use a range of activities to fulfill the program's mission of advancing innovative research to improve delivery of care across the cancer control continuum. In addition to developing funding opportunities, HDRP staff; support and facilitate the use of research infrastructure for conducting health-care delivery research; oversee publicly available data that can be used to evaluate patterns, costs, and patient experiences of care; contribute to development and dissemination of standardized health measurement tools for public use; and support professional development and training to build capacity within the field and grow the workforce. As HDRP enters its sixth year, we appreciate the opportunity to reflect on the program's progress in advancing the science of health-care delivery. At the same time, we recognize the need for the program to evolve and develop additional resources and opportunities to address new and emerging challenges.

Identifiants

pubmed: 33993284
pii: 6276437
doi: 10.1093/jnci/djab096
pmc: PMC8755485
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

20-24

Informations de copyright

Published by Oxford University Press 2021. This work is written by US Government employees and is in the public domain in the US.

Références

J Cancer Surviv. 2021 Jun;15(3):370-374
pubmed: 33651327
Lancet Oncol. 2017 Nov;18(11):e653-e706
pubmed: 29208398
JAMA Oncol. 2019 Mar 1;5(3):298-299
pubmed: 30570655
Cancer J. 2018 May/Jun;24(3):126-130
pubmed: 29794537
Am J Public Health. 2011 Dec;101 Suppl 1:S149-55
pubmed: 21551385
JAMA Oncol. 2020 Nov 1;6(11):1698-1699
pubmed: 32672821
Cancer Res. 2017 Sep 1;77(17):4548-4555
pubmed: 28739629
Cancers (Basel). 2020 Dec 08;12(12):
pubmed: 33302472
Cancer. 2020 May 15;126(10):2225-2249
pubmed: 32162336
N Engl J Med. 2021 Feb 25;384(8):768-773
pubmed: 33326717
J Clin Oncol. 2019 Jan 10;37(2):93-96
pubmed: 30407894
J Natl Cancer Inst. 2020 Jun 1;112(6):557-561
pubmed: 31845965
Health Policy Open. 2020 Dec;1:100015
pubmed: 33073235
J Natl Cancer Inst Monogr. 2012 May;2012(44):2-10
pubmed: 22623590
Cancer Epidemiol Biomarkers Prev. 2017 Jul;26(7):992-997
pubmed: 28600296
Breast. 2017 Feb;31:167-172
pubmed: 27871024
JCO Clin Cancer Inform. 2018 Dec;2:1-9
pubmed: 30652580
J Clin Oncol. 2020 Feb 1;38(4):292-301
pubmed: 31804869
J Clin Oncol. 2017 Sep 1;35(25):2871-2874
pubmed: 28628364

Auteurs

Paul B Jacobsen (PB)

Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.

Janet de Moor (J)

Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.

V Paul Doria-Rose (VP)

Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.

Ann M Geiger (AM)

Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.

Sarah C Kobrin (SC)

Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.

Annie Sampson (A)

Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.

Ashley Wilder Smith (AW)

Healthcare Delivery Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH